Stepwise identification of HLA-A*0201-restricted CD8+ T-cell epitope peptides from herpes simplex virus type 1 genome boosted by a StepRank scheme.

Identification of immunodominant epitopes is the first step in the rational design of peptide vaccines aimed at T-cell immunity. To date, however, it is yet a great challenge for accurately predicting the potent epitope peptides from a pool of large-scale candidates with an efficient manner. In this study, a method that we named StepRank has been developed for the reliable and rapid prediction of binding capabilities/affinities between proteins and genome-wide peptides. In this procedure, instead of single strategy used in most traditional epitope identification algorithms, four steps with different purposes and thus different computational demands are employed in turn to screen the large-scale peptide candidates that are normally generated from, for example, pathogenic genome. The steps 1 and 2 aim at qualitative exclusion of typical nonbinders by using empirical rule and linear statistical approach, while the steps 3 and 4 focus on quantitative examination and prediction of the interaction energy profile and binding affinity of peptide to target protein via quantitative structure-activity relationship (QSAR) and structure-based free energy analysis. We exemplify this method through its application to binding predictions of the peptide segments derived from the 76 known open-reading frames (ORFs) of herpes simplex virus type 1 (HSV-1) genome with or without affinity to human major histocompatibility complex class I (MHC I) molecule HLA-A*0201, and find that the predictive results are well compatible with the classical anchor residue theory and perfectly match for the extended motif pattern of MHC I-binding peptides. The putative epitopes are further confirmed by comparisons with 11 experimentally measured HLA-A*0201-restrcited peptides from the HSV-1 glycoproteins D and K. We expect that this well-designed scheme can be applied in the computational screening of other viral genomes as well.

[1]  David Heckerman,et al.  Broad and Gag-Biased HIV-1 Epitope Repertoires Are Associated with Lower Viral Loads , 2008, PloS one.

[2]  Alessandro Sette,et al.  The Immune Epitope Database 2.0 , 2009, Nucleic Acids Res..

[3]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[4]  Ken Chen,et al.  Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis. , 2005, Journal of proteome research.

[5]  D. Flower,et al.  Physicochemical explanation of peptide binding to HLA‐A*0201 major histocompatibility complex: A three‐dimensional quantitative structure‐activity relationship study , 2002, Proteins.

[6]  Y. Hiasa,et al.  Identification of CTL epitopes in hepatitis C virus by a genome-wide computational scanning and a rational design of peptide vaccine , 2007, Immunogenetics.

[7]  Ellis L Reinherz,et al.  Genome-wide Characterization of a Viral Cytotoxic T Lymphocyte Epitope Repertoire* , 2003, Journal of Biological Chemistry.

[8]  Hanah Margalit,et al.  A structure-based approach for prediction of MHC-binding peptides. , 2004, Methods.

[9]  Irini Doytchinova,et al.  The HLA-A2-supermotif: a QSAR definition. , 2003, Organic & biomolecular chemistry.

[10]  S. Wold,et al.  New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. , 1998, Journal of medicinal chemistry.

[11]  D. Flower,et al.  Additive method for the prediction of protein-peptide binding affinity. Application to the MHC class I molecule HLA-A*0201. , 2002, Journal of proteome research.

[12]  Yoshihiro Yamaguchi,et al.  Roles for the Two-hybrid System in Exploration of the Yeast Protein Interactome* , 2002, Molecular & Cellular Proteomics.

[13]  Naoki Abe,et al.  Empirical Evaluation of a Dynamic Experiment Design Method for Prediction of MHC Class I-Binding Peptides1 , 2002, The Journal of Immunology.

[14]  Pingping Guan,et al.  Quantitative structure-activity relationships and the prediction of MHC supermotifs. , 2004, Methods.

[15]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[16]  H. M. Geysen,et al.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Welling,et al.  B and T cell epitopes of glycoprotein D of herpes simplex virus type 1. , 1991, FEMS microbiology immunology.

[18]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[19]  J. Leunissen,et al.  Definition of natural T cell antigens with mimicry epitopes obtained from dedicated synthetic peptide libraries. , 1998, Journal of immunology.

[20]  L. Payne,et al.  Potent protective cellular immune responses generated by a DNA vaccine encoding HSV-2 ICP27 and the E. coli heat labile enterotoxin. , 2006, Vaccine.

[21]  S. Wechsler,et al.  The role of a glycoprotein K (gK) CD8+ T-cell epitope of herpes simplex virus on virus replication and pathogenicity. , 2009, Investigative ophthalmology & visual science.

[22]  P. Visscher,et al.  The Genetic Interpretation of Area under the ROC Curve in Genomic Profiling , 2010, PLoS genetics.

[23]  A. Nesburn,et al.  A Novel HLA (HLA-A*0201) Transgenic Rabbit Model for Preclinical Evaluation of Human CD8+ T Cell Epitope-Based Vaccines against Ocular Herpes , 2010, The Journal of Immunology.

[24]  F. Aoki,et al.  Glycoprotein-D-adjuvant vaccine to prevent genital herpes. , 2002, The New England journal of medicine.

[25]  L. BenMohamed,et al.  Gender-Dependent HLA-DR-Restricted Epitopes Identified from Herpes Simplex Virus Type 1 Glycoprotein D , 2008, Clinical and Vaccine Immunology.

[26]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[27]  Andrew J Davison,et al.  Topics in herpesvirus genomics and evolution. , 2006, Virus research.

[28]  Roland L. Dunbrack,et al.  proteins STRUCTURE O FUNCTION O BIOINFORMATICS Improved prediction of protein side-chain conformations with SCWRL4 , 2022 .

[29]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[30]  H. Rammensee,et al.  SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.

[31]  M R Lee,et al.  Use of MM‐PB/SA in estimating the free energies of proteins: Application to native, intermediates, and unfolded villin headpiece , 2000, Proteins.

[32]  J. Sidney,et al.  Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.

[33]  A. Nesburn,et al.  Local Periocular Vaccination Protects against Eye Disease More Effectively Than Systemic Vaccination following Primary Ocular Herpes Simplex Virus Infection in Rabbits , 1998, Journal of Virology.

[34]  A. Nesburn,et al.  A therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal disease. , 1998, Investigative ophthalmology & visual science.

[35]  Vladimir Brusic,et al.  Predicting peptides binding to MHC class II molecules using multi-objective evolutionary algorithms , 2007, BMC Bioinformatics.

[36]  J. Scott,et al.  Searching for peptide ligands with an epitope library. , 1990, Science.

[37]  Irini A. Doytchinova,et al.  Predicting Class I Major Histocompatibility Complex (MHC) Binders Using Multivariate Statistics: Comparison of Discriminant Analysis and Multiple Linear Regression , 2007, J. Chem. Inf. Model..

[38]  A Sette,et al.  Definition of specific peptide motifs for four major HLA-A alleles. , 1994, Journal of immunology.

[39]  Hu Mei,et al.  A set of new amino acid descriptors applied in prediction of MHC class I binding peptides. , 2009, European journal of medicinal chemistry.

[40]  D. Flower,et al.  Toward the quantitative prediction of T-cell epitopes: coMFA and coMSIA studies of peptides with affinity for the class I MHC molecule HLA-A*0201. , 2001, Journal of medicinal chemistry.

[41]  F. Aoki,et al.  Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  F. Tian,et al.  In silico quantitative prediction of peptides binding affinity to human MHC molecule: an intuitive quantitative structure–activity relationship approach , 2009, Amino Acids.

[43]  J. Schneider-Mergener,et al.  Applications of peptide arrays prepared by the SPOT-technology. , 2001, Current opinion in biotechnology.

[44]  S. Wold,et al.  PLS-regression: a basic tool of chemometrics , 2001 .

[45]  Ken Chen,et al.  Computational Analysis and Prediction of the Binding Motif and Protein Interacting Partners of the Abl SH3 Domain , 2006, PLoS Comput. Biol..

[46]  K. Lam,et al.  Combinatorial peptide library methods for immunobiology research. , 2003, Experimental hematology.

[47]  K. Parker,et al.  Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.

[48]  R. Frank.  The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications. , 2002, Journal of immunological methods.

[49]  W. Kwok,et al.  Recognition of Herpes Simplex Virus Type 2 Tegument Proteins by CD4 T Cells Infiltrating Human Genital Herpes Lesions , 1998, Journal of Virology.

[50]  K. Rosenthal,et al.  Ligand epitope antigen presentation system vaccines against herpes simplex virus. , 2005, Frontiers in bioscience : a journal and virtual library.

[51]  F. Tian,et al.  A Structure‐based, Quantitative Structure–Activity Relationship Approach for Predicting HLA‐A*0201‐restricted Cytotoxic T Lymphocyte Epitopes , 2007, Chemical biology & drug design.

[52]  Morten Nielsen,et al.  A Community Resource Benchmarking Predictions of Peptide Binding to MHC-I Molecules , 2006, PLoS Comput. Biol..

[53]  J. Rajčáni,et al.  Peculiarities of Herpes Simplex Virus (HSV) Transcription: An overview , 2004, Virus Genes.

[54]  E. Reinherz,et al.  Prediction of MHC class I binding peptides using profile motifs. , 2002, Human immunology.

[55]  B. Roux,et al.  Implicit solvent models. , 1999, Biophysical chemistry.

[56]  Irini A. Doytchinova,et al.  Towards the chemometric dissection of peptide – HLA-A*0201 binding affinity: comparison of local and global QSAR models , 2005, J. Comput. Aided Mol. Des..

[57]  C. Pinilla,et al.  Use of combinatorial peptide libraries for T-cell epitope mapping. , 2003, Methods.

[58]  Andrew P. Bradley,et al.  The use of the area under the ROC curve in the evaluation of machine learning algorithms , 1997, Pattern Recognit..

[59]  Maria Jesus Martin,et al.  The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 , 2003, Nucleic Acids Res..

[60]  W. Dunn,et al.  Amino acid side chain descriptors for quantitative structure-activity relationship studies of peptide analogues. , 1995, Journal of medicinal chemistry.

[61]  K. Lamberth,et al.  HLA-A*0201-Restricted CD8+ Cytotoxic T Lymphocyte Epitopes Identified from Herpes Simplex Virus Glycoprotein D1 , 2008, The Journal of Immunology.